Study to Characterize the Pharmacokinetics of a Single Dose of SC Abatacept 125 mg Using the BD Autoinjector or the Prefilled Syringe

PHASE1CompletedINTERVENTIONAL
Enrollment

356

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Abatacept

Trial Locations (25)

33

Local Institution, Lima

1646

Local Institution, San Fernando

2000

Local Institution, Rosario

4000

Local Institution, San Miguel de Tucumán

5000

Local Institution, Córdoba

5016

Local Institution, Córdoba

6001

Local Institution, Port Elizabeth

6529

Local Institution, George

16635

Altoona Center For Clinical Research, Duncansville

27612

Wake Research Associates, Raleigh

28144

Pmg Research Of Salisbury, Salisbury

28210

Djl Research, Pllc, Charlotte

28401

Pmg Research Of Wilmington Llc, Wilmington

32117

Covance Cru Inc, Daytona Beach

35801

Rheumatology Associates Of North Alabama, P.C., Huntsville

45255

Community Research, Cincinnati

67207

Heartland Research Associates, Llc, Wichita

68516

Physician Research Collaboration, Llc, Lincoln

75247

Covance Clinical Research Unit Inc., Dallas

80112

Immunoe Int'L Research Ctrs, Centennial

97000

Local Institution, Yucatán

01605

Clinical Pharmacology Study Group, Worcester

LIMA 01

Local Institution, Lima

0122

Local Institution, Pretoria

0184

Local Institution, Pretoria

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT01890473 - Study to Characterize the Pharmacokinetics of a Single Dose of SC Abatacept 125 mg Using the BD Autoinjector or the Prefilled Syringe | Biotech Hunter | Biotech Hunter